Nathan S Bryan1. 1. Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Alkek Building for Biomedical Research R-850, Houston, TX, 77030, USA. Nathan.bryan@bcm.edu.
Abstract
PURPOSE OF REVIEW: To reveal the mechanisms of nitric oxide (NO) production in humans and how lifestyle, drug therapy, and hygienic practices can decrease NO production. Furthermore, to show how functional nitric oxide nutrition can overcome these limitations to restore endogenous NO production and combat cardiovascular disease. RECENT FINDINGS: Research over the past decade has revealed that inorganic nitrate and nitrite found naturally in green leafy vegetables and other vegetables such as beets can provide the human body with a source of bioactive nitric oxide. NO is one of the most important molecules produced within the cardiovascular system that maintains normal blood pressure and prevents inflammation, immune dysfunction, and oxidative stress, hallmarks of cardiovascular disease. This pathway is dependent upon the amount of inorganic nitrate and nitrite in the foods we eat, the presence of oral nitrate-reducing bacteria, and sufficient stomach acid production. The concept of food being medicine and medicine being food has lost its place in the practice and implementation of modern medicine over the past century. Certain dietary patterns and specific foods are known to confer very significant protective effects for many human diseases, including cardiovascular disease, the number one killer of men and women in the developed world. However, identification of single or multiple bioactive molecules that are responsible for these effects has escaped scientists and nutritionists for many years. This review will highlight the biochemical, physiological, and epidemiological basis for functional nitric oxide nutrition that can be safely and effectively utilized in patients.
PURPOSE OF REVIEW: To reveal the mechanisms of nitric oxide (NO) production in humans and how lifestyle, drug therapy, and hygienic practices can decrease NO production. Furthermore, to show how functional nitric oxide nutrition can overcome these limitations to restore endogenous NO production and combat cardiovascular disease. RECENT FINDINGS: Research over the past decade has revealed that inorganic nitrate and nitrite found naturally in green leafy vegetables and other vegetables such as beets can provide the human body with a source of bioactive nitric oxide. NO is one of the most important molecules produced within the cardiovascular system that maintains normal blood pressure and prevents inflammation, immune dysfunction, and oxidative stress, hallmarks of cardiovascular disease. This pathway is dependent upon the amount of inorganic nitrate and nitrite in the foods we eat, the presence of oral nitrate-reducing bacteria, and sufficient stomach acid production. The concept of food being medicine and medicine being food has lost its place in the practice and implementation of modern medicine over the past century. Certain dietary patterns and specific foods are known to confer very significant protective effects for many human diseases, including cardiovascular disease, the number one killer of men and women in the developed world. However, identification of single or multiple bioactive molecules that are responsible for these effects has escaped scientists and nutritionists for many years. This review will highlight the biochemical, physiological, and epidemiological basis for functional nitric oxide nutrition that can be safely and effectively utilized in patients.
Authors: Frank L Greenway; Benjamin L Predmore; Douglas R Flanagan; Tony Giordano; Yang Qiu; Angela Brandon; David J Lefer; Rakesh P Patel; Christopher G Kevil Journal: Diabetes Technol Ther Date: 2012-04-02 Impact factor: 6.118
Authors: Maryuri T Nuñez De González; Wesley N Osburn; Margaret D Hardin; Michael Longnecker; Harsha K Garg; Nathan S Bryan; Jimmy T Keeton Journal: J Agric Food Chem Date: 2012-04-05 Impact factor: 5.279
Authors: S D Gangolli; P A van den Brandt; V J Feron; C Janzowsky; J H Koeman; G J Speijers; B Spiegelhalder; R Walker; J S Wisnok Journal: Eur J Pharmacol Date: 1994-11-01 Impact factor: 4.432
Authors: Embriette R Hyde; Fernando Andrade; Zalman Vaksman; Kavitha Parthasarathy; Hong Jiang; Deepa K Parthasarathy; Ashley C Torregrossa; Gena Tribble; Heidi B Kaplan; Joseph F Petrosino; Nathan S Bryan Journal: PLoS One Date: 2014-03-26 Impact factor: 3.240
Authors: Nur Aqilah Kamaruddin; Muhammad Nazrul Hakim Abdullah; Jun Jie Tan; Vuanghao Lim; Lai Yen Fong; Siti Aisyah Abd Ghafar; Yoke Keong Yong Journal: Evid Based Complement Alternat Med Date: 2022-04-16 Impact factor: 2.650
Authors: Dina A I Albadawi; Divyashree Ravishankar; Thomas M Vallance; Ketan Patel; Helen M I Osborn; Sakthivel Vaiyapuri Journal: Int J Mol Sci Date: 2022-01-06 Impact factor: 6.208
Authors: Paul Stamm; Sanela Kalinovic; Matthias Oelze; Sebastian Steven; Alexander Czarnowski; Miroslava Kvandova; Franziska Bayer; Christoph Reinhardt; Thomas Münzel; Andreas Daiber Journal: Biomedicines Date: 2022-03-21